MedPath

天方药业有限公司

Ownership
-
Established
2013-11-13
Employees
-
Market Cap
-
Website
https://www.topfond.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

368

NMPA:368

Drug Approvals

Clopidogrel Bisulfate Tablets

Product Name
硫酸氢氯吡格雷片
Approval Number
国药准字H20254305
Approval Date
May 27, 2025
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20258023
Approval Date
Mar 5, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20253445
Approval Date
Feb 25, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20253444
Approval Date
Feb 25, 2025
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字H20249545
Approval Date
Dec 1, 2024
NMPA

Atomoxetine Hydrochloride Capsules

Product Name
盐酸托莫西汀胶囊
Approval Number
国药准字H20247297
Approval Date
Nov 28, 2024
NMPA

Norepinephrine Bitartrate Injection

Product Name
重酒石酸去甲肾上腺素注射液
Approval Number
国药准字H20249334
Approval Date
Nov 15, 2024
NMPA

Betahistine Hydrochloride Tablets

Product Name
盐酸倍他司汀片
Approval Number
国药准字H20247121
Approval Date
Jun 5, 2024
NMPA

Albendazole Tablets

Product Name
阿苯达唑片
Approval Number
国药准字H41021567
Approval Date
Apr 12, 2024
NMPA

Promethazine Hydrochloride Tablets

Product Name
盐酸异丙嗪片
Approval Number
国药准字H41023300
Approval Date
Apr 7, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 37
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.